发明名称 P2X3, receptor antagonists for treatment of pain
摘要 The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
申请公布号 US8946231(B2) 申请公布日期 2015.02.03
申请号 US201013259087 申请日期 2010.03.15
申请人 Merck Sharp & Dohme Corp. 发明人 Burgey Christopher S.;Potteiger Craig M.
分类号 C07D401/14;A61K31/42;C07D413/12;A61K31/195;A61K31/415;A61K33/00;A61K45/06;C07D413/14;C07D417/14 主分类号 C07D401/14
代理机构 代理人 Ayler Sylvia A.;Todaro John C.
主权项 1. A compound represented by structural formula II:or pharmaceutically acceptable salts and individual enantiomers and diastereomers thereof wherein: A is CH or N; Rb is C1-6 alkyl, or halogen; R2 represents H, C1-6 alkyl, CF3, OH; R3 represents (CHR2)nC5-10 heterocycle,said heterocyclyl substituted with 1 to 3 groups of Ra , wherein R2 in (CHR2)nC5-10 heterocycle is C1-6 alkyl which is methyl and n in (CHR2)nC5-10 heterocycle is 1 ; R6 represents C1-6 alkyl, (CHR2)nC6-10 aryl, (CHR2)nC5-10 heterocyclyl, said alkyl, aryl and heterocyclyl optionally substituted with 1 to 3 groups of Ra ; Ra represents C1-6 alkyl, halogen, OR2, (CH2)nCF3 , —O—, C3-6 cycloalkyl, C(O)N(R2)2, C(O)R2, CN, N(R2)2, C(O)OR2, SO2R2,(CHR2)nC5-10 heterocyclyl, or (CHR2)nC6-10 aryl, said heterocyclyl and aryl optionally substituted with 1 to 3 groups of C1-6 alkyl, halogen, hydroxyl, (CH2)nCF3,or CN; and n represents 0 to 4.
地址 Rahway NJ US